Heparina Sódica Sala

Heparina Sódica Sala is a pharmaceutical product containing the active ingredient heparin sodium. It is supplied in a sterile solution intended for intravenous, intra‑arterial, and haemodialysis administration. The preparation is marketed in the European Union and is classified as a prescription‑only anticoagulant used to reduce the risk of clot formation during medical procedures.

Heparina Sódica Sala is employed in clinical settings where rapid anticoagulation is required. It is indicated for several therapeutic situations:

- Prevention of clot formation during haemodialysis sessions. - Intra‑arterial anticoagulation during interventional radiology or cardiac catheterisation. - Intravenous anticoagulation for patients with acute thrombotic disorders. - Supportive therapy in surgeries that carry a high risk of thrombosis. - Management of extracorporeal circulation circuits such as cardiopulmonary bypass.

Heparina Sódica Sala may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common: - Minor bleeding at the infusion site. - Small bruising or ecchymoses. - Transient elevation of liver enzymes. - Mild nausea or vomiting. - Localised pain or irritation at the injection site.

Serious: - Major hemorrhage, including internal bleeding. - Heparin‑induced thrombocytopenia (HIT). - Allergic reactions such as urticaria or anaphylaxis. - Spontaneous spinal or epidural hematoma. - Severe hypotension due to rapid infusion.

Before using Heparina Sódica Sala, clinicians should consider several safety factors to minimise risk. Important precautions include:

- Assess patient history for bleeding disorders or recent surgery. - Monitor activated partial thromboplastin time (aPTT) or anti‑Xa levels during therapy. - Use reduced doses in patients with renal impairment or the elderly. - Avoid use in individuals with known hypersensitivity to heparin or pork products. - Evaluate pregnancy status; the safety profile is not well established. - Discontinue promptly if signs of heparin‑induced thrombocytopenia appear.

Heparina Sódica Sala can interact with other medications, influencing its anticoagulant effect or increasing bleeding risk.

Avoid: - Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants). - High‑dose antiplatelet agents such as clopidogrel or aspirin. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that impair platelet function.

Use with caution: - Thrombolytic agents (e.g., alteplase) during acute clot dissolution. - Certain antibiotics like vancomycin that may potentiate anticoagulation. - Herbal supplements with anticoagulant properties (e.g., ginkgo, garlic). - Corticosteroids that may affect vascular integrity.